AJCR Copyright © 2010-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA
Forthcoming Titles

(PDFs in this page may have not been proofed yet)

Amy C Sievers, Joseph H. Antin: Post-transplant lymphoproliferative disorders, a review. Am J Cancer Res 2017;7(x):xxx-xxx.

Tanya Kalin, et al: Signaling pathways regulated by FoxM1 oncogene in lung cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Ann Richmond, et al: Interrelationship between aurora kinaseA  and inhibitor of kappa-beta kinase (IKK) inhibition in melanoma. Am J Cancer Res 2017;7(x):xxx-xxx.

Stephen A. Boppart, et al: Ultrastructural changes during tumor development detected by polarization-sensitivie optical coherence tomography. Am J Cancer Res 2017;7(x):xxx-xxx.

Franca Esposito, et al: New insights into the TRAP1 pathway. Am J Cancer Res 2017;7(x):xxx-xxx.

Jenny Wang, et al: TGFb-mediated suppression of metastasis in colon cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Dan A. Liebermann, et al: Gadd45 family of genes sensors of i oncogenic stress. Am J Cancer Res 2017;7(x):xxx-xxx.

Bharat B. Aggarwal, et al: Inflammation and cancer: a story of association and dissociation. Am J Cancer Res 2017;7(x):xxx-xxx.

Michael A. Tainsky, et al: Innate immunity in cancer development. Am J Cancer Res 2017;7(x):xxx-xxx.

Elizabeth Moran, et al: Molecular role of the retinoblastoma family in suppression of osteosarcoma, and in control of normal osteoblast differentiation. Am J Cancer Res 2017;7(x):xxx-xxx.

Jong-Wan Park, et al: Does HIF promote or demote skin cancer? Am J Cancer Res 2017;7(x):xxx-xxx.

Asit K. De, et al: Role of heat shock protein 27 in human cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Hyeong-Reh Choi Kim, et al: A novel mechanism of PDGF signaling in human cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Elizabeth M. Wilson, et al: Androgen receptor action in prostate cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

François E. Paris, et al: Ionizing radiation induces acute and long terms responses  in endothelial cells. Am J Cancer Res 2017;7(x):xxx-xxx.

Dmitry Pshezhetskiy, et al: Bacterial infection mediates prostate cancer progression through activation of sphingosine kinase 1. Am J Cancer Res 2017;7(x):xxx-xxx.

Xiang-ping Li, et al: Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Am J Cancer Res 2017;7(x):xxx-xxx.

Franceca Ricci, Massimo Broggini, Giovanna Damia: Tumor initianting cell of ovarian cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Chiun Hsu, et al: "off-target" effects of sorafenib for the treatment of hepatocellular carcinoma: translational and clinical implications. Am J Cancer Res 2017;7(x):xxx-xxx.

Gopal C. Kundu, et al: Osteopontin, a potentially important therapeutic target in cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Stephen H. Thorne, et al: Combining biological therapies for optimal treatment of cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Patrick Pollard, et al: Metabolic biomarkers: a new era in cancer identification and stratification. Am J Cancer Res 2017;7(x):xxx-xxx.

Olivier Cuvillier, et al: Sphingosine 1-phosphate, a cancer therapeutic target. Am J Cancer Res 2017;7(x):xxx-xxx.

Stephanie Ma, et al: microRNA regulation in cancer stem cells. Am J Cancer Res 2017;7(x):xxx-xxx.

Dina Allam, Leo K. Iwai, Paul H. Huang: Discoidin domain receptor signalling networks in cancer. Am J Cancer Res 2013;3(x):xxx-xxx.

Mong-Hong Lee, et al: Role of 14.33 sigma in DNA damage response. Am J Cancer Res 2017;7(x):xxx-xxx.

Qiuyin Cai, et al:  Mitochondrial DNA variations with breast cancer risk and outcome. Am J Cancer Res 2017;7(x):xxx-xxx.

Jacques E. Nor, et al: Stem cells in salivary gland cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

James A. Koziol, Zhenyu Jia, Michael B. Lilly, Dan A. Mercola: The use of nomogram predictions as comparators for adjuvant treatment studies in prostate cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Durga Udayakumar, Hensin Tsao: Role of Eph Receptors in Cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Fahd Al-Mulla, et al: RKIP interacts with KEAP1 to promote chemotherapeutic resistance. Am J Cancer Res 2017;7(x):xxx-xxx.

Yangbing Zhao, et al: Influence of T cell stimulation on anti-tumor activities of RNA electroporated T cells. Am J Cancer Res 2017;7(x):xxx-xxx.

Fahd Al-Mulla, et al: Chromothripsis in colorectal cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Mei-Yi Lee, Cheng-Yang Chou, Meng-Ru Shen: Epithelial-mesenchymal transition in cervical cancer. Am J Cancer Res 2013;3(x):xxx-xxx.

Zanella F, García B, Callejas S, Peregrina S, Carnero A, Wolfgang Link: Chemical genetic rescue profiling for target deconvolution.  Am J Cancer Res 2017;7(x):xxx-xxx.

Zhenyu Jia, Yipeng Wang, Kai Ye, Xiao-Qin Xia, Yuanjie Hu, Hui Li, Sha Tang, Waldemar Lernhardt, James A. Koziol, Michael McClelland, Dan Mercola: Increasing sample size does not boost power if confounding factors are not controlled – a study of prostate cancer expression profiles. Am J Cancer Res 2017;7(x):xxx-xxx.

Daniel Monleon, et al: Cancer metabolism beyond the Warburg effect. Am J Cancer Res 2017;7(x):xxx-xxx.

Guido Kroemer: Autophagic cell death in cancer therapy.  Am J Cancer Res 2017;7(x):xxx-xxx.

Claudio Sorio, et al: Applications of Fourier transformed microspectroscopy in cancer research. Am J Cancer Res 2017;7(x):xxx-xxx.

Samir Iqbal, et al: Nanotechnology for cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Hinrich Gronemeyer: Epigenetic regulation of cancer-selective TRAIL-mediated apoptosis. Am J Cancer Res 2017;7(x):xxx-xxx.

Margaret A. Knowles: Preclinical models for bladder cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Subbaya Subramanian, et al: MicroRNA gene regulatory newtorks in sarcomas. Am J Cancer Res 2017;7(x):xxx-xxx.

Maurizio D’Incalci, et al: Mechanism of action of marine natural products with antitumor properties.Am J Cancer Res 2013;3(x):xxx-xxx.

Lucio Miele, et al: Notch signaling in breast cancer: context dependence and therapeutic targeting. Am J Cancer Res 2013;3(x):xxx-xxx.

Max Costa, et al: Histone tail modifications and Cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Ali Jazirehi, et al: Bortezomib for the treatment of melanoma. Am J Cancer Res 2017;7(x):xxx-xxx.

Donald J. Johann, et al: Advancing molecular profiling with mass spectrometry based clinical proteomics. Am J Cancer Res 2017;7(x):xxx-xxx.

Michael L. Freeman, et al: Repression of Nrf2 signaling. Am J Cancer Res 2017;7(x):xxx-xxx.

Michael J. Seckl, et al: Targeting the JAK/STAT signalling pathway in cancer.  Am J Cancer Res 2017;7(x):xxx-xxx.

Andrew E. Aplin, et al: FOXD3 regulation of migration in melanoma. Am J Cancer Res 2017;7(x):xxx-xxx.

Thomas Helleday: The synthetic lethal concept for novel cancer treatments: potentials and pitfalls. Am J Cancer Res 2013;3(x):xxx-xxx.

Vincent L. Cryns: Molecular chaperones and cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Francois X. Claret, et al: Evolving Strategies for treatment of HER2-positive breast cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Alfredo Fusco, et al: RNA and microRNA expression profile in pituitary adenomas. Am J Cancer Res 2017;7(x):xxx-xxx.

Su Hao Lo, et al: The dual roles of cten in tumorigenesis. Am J Cancer Res 2017;7(x):xxx-xxx.

Ben Ho Park:  Androgen receptor as a targeted therapy for breast cancer (mini-review). Am J Cancer Res 2017;7(x):xxx-xxx.

Philip Hahnfeldt, et al: Intercellular interactions as a modulator of carcinogenesis and cancer progression. Am J Cancer Res 2017;7(x):xxx-xxx.

Markus H. Frank, et al: Role of ABCB5 in cancer multidrug resistance. Am J Cancer Res 2017;7(x):xxx-xxx.

Tohru Kiyono, et al: An in vitro multistep carcinogenesis model for both HPV- positive and -negative human oral squamous cell carcinoma.  Am J Cancer Res 2017;7(x):xxx-xxx.

Ratna K. Vadlamudi, et al: MicroRNA signaling in breast cancer: novel therapeutics. Am J Cancer Res 2017;7(x):xxx-xxx.

David M. Owens, et al: Dissecting the role of CD200 signaling in tumor progression and metastasis. Am J Cancer Res 2013;3(x):xxx-xxx.

Balakrishna L. Lokeshwar, et al: Spicing up anticancer medicine: time to seriously consider dietary anticancer compounds in cancer therapy. Am J Cancer Res 2017;7(x):xxx-xxx.

Shanaz H. Dairkee, et al: Novel cancer models to assist in oncogenic pathway identification. Am J Cancer Res 2017;7(x):xxx-xxx.

Gutian Xiao, et al: Negative regulation of NF-kappaB in cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Paul Szabolcs, et al: Challenges and opportunities: immune reconstitution after cord blood transplantation. Am J Cancer Res 2017;7(x):xxx-xxx.

Zdenko Herceg, et al: Epigenetic mechanisms, stem cells and cancer (review). Am J Cancer Res 2017;7(x):xxx-xxx.

Venuprasad K. Poojary, et al: TGF-beta and regulation of anti-tumor immune response. Am J Cancer Res 2017;7(x):xxx-xxx.

Shi-Yong Sun, et al: Impact of genetic alterations on mTOR-targeted cancer therapy. Am J Cancer Res 2017;7(x):xxx-xxx.

Othon Iliopoulos, et al: HIF2a as a therapeutic target for cancer angiogenesis. Am J Cancer Res 2017;7(x):xxx-xxx.

Hari K Koul, et al:  Tetrandrine targets cell cycle to inhibit prostate cancer growth. Am J Cancer Res 2017;7(x):xxx-xxx.

Godefridus J. Peters, et al: Translation of animal models to the patient; why do they not always work? Am J Cancer Res 2017;7(x):xxx-xxx.

Ester Hammond, et al: DNA damage signalling in hypoxia. Am J Cancer Res 2017;7(x):xxx-xxx.

Jiaoti Huang, et al: Cell origin for prostate cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

Shuichi Kaneko, et al: Stem cells of hepatocellular carcinoma. Am J Cancer Res 2017;7(x):xxx-xxx.

Bo Huang, et al:  Mast cells: toward the road of remodeling tumor microenvironment. Am J Cancer Res 2017;7(x):xxx-xxx.

Haval Shirwan: Cancer vaccines, an update. Am J Cancer Res 2017;7(x):xxx-xxx.

Masamitsu Yamaguchi, et al: Regulation of Hippo pathway genes by DRE/DREF system. Am J Cancer Res 2017;7(x):xxx-xxx.

Karim Nayernia, et al: PhD,Cancer stem cells: a new approaches for diagnostics and therapy. Am J Cancer Res 2017;7(x):xxx-xxx.

Matthew L.  Anderson: MicroRNAs in gynecologic cancer. Am J Cancer Res 2017;7(x):xxx-xxx.

M.R. Satyanarayana Rao, et al: Molecular and Cellular heterogeneity of Glioma. Am J Cancer Res 2017;7(x):xxx-xxx.

Qian Zheng, et al: Can chemotherapy be individualized in prostate cancer? Am J Cancer Res 2017;7(x):xxx-xxx.

Pablo Menendez, et al: Modelling sarcomas using MSCs. Am J Cancer Res 2017;7(x):xxx-xxx.

Kosaku Iwatsubo, et al: Epac1 as a mediator of melanoma metastasis. Am J Cancer Res 2017;7(x):xxx-xxx.

Sam Thiagalingam, et al: Epigenetic regulation of breast cancer progression. Am J Cancer Res 2017;7(x):xxx-xxx.

Christopher H. Parsons, et al: SHV interactions with the cell surface: new paradigms for HIV-associated cancer pathogenesis and the development of novel therapeutic approaches. Am J Cancer Res 2017;7(x):xxx-xxx.

Yuval Shaked, et al: The role of bone marrow derived cells in tumor angiogenesis and growth. Am J Cancer Res 2017;7(x):xx-xx.

Irina Nazarenko, et al: Different modes of intercellular communication and their impact on tumour progression. Am J Cancer Res 2017;7(x):xx-xx.

Anjali Jain, et al: Targeting mTOR in PTEN-null NSCLC after acquired resistance to EGFR-TKIs. Am J Cancer Res 2017;7(x):xx-xx.

François Ghiringhelli: Targeting myeloid derived suppressor cells to relieve tumor induce immunosuppression. Am J Cancer Res 2017;7(x):xx-xx.

Mark W Jackson, et al: Defining novel tumor suppressor-oncogene interactions in mammary cell transformation. Am J Cancer Res 2017;7(x):xx-xx.

Wenxing Zheng, et al: Secretory cells of fallopian tube as the main source for female pelvic serous carcinoma. Am J Cancer Res 2017;7(x):xx-xx.

Sandra Orsulic, et al: Expression of HOXB13 in adult human tissues and its relevance to cancer. Am J Cancer Res 2017;7(x):xx-xx.

Jeanette H.W. Leusen, et al: Mechanisms of antibody therapy for cancer. Am J Cancer Res 2017;7(x):xx-xx.

Stephen Safe, et al: The effects of some anticancer drugs on growth inhibition and Sp transcription factor downregulation in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Prahlad T. Ram, et al: Signaling and mutations in RTK and GPCR networks in melanoma. Am J Cancer Res 2017;7(x):xx-xx.

Qi Dai, et al: Major contributors to isoprotane metabolite, an accurate biomarker for oxidative stress. Am J Cancer Res 2012;2(x):xx-xx.

Jean-Marc A. Lobaccaro, et al: Cholesterol, prostate cancer and LXR: the good, the bad and the ugly. Am J Cancer Res 2017;7(x):xx-xx.

Eitan Shaulian, et al: New mechanisms and target mediating AP-1 activity in transformation. Am J Cancer Res 2017;7(x):xx-xx.

Guojun Wu, et al: EMT and metastatic breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Franco Capozza, et al: Caveolae/Caveolins in skin cancer progression. Am J Cancer Res 2017;7(x):xx-xx.

Devanand Sarkar, et al: The transcription factor LSF: a novel oncogene for hepatocellular carcinoma. Am J Cancer Res 2012;2(x):xx-xx.

Bin Zhang, et al: Overcoming CD39/CD73-mediated cancer immune evasion. Am J Cancer Res 2017;7(x):xx-xx.

Sandro De Falco, et al: Over-expression of a PlGF2 variant in tumor cells inhibits VEGF-dependent tumor angiogenesis. Am J Cancer Res 2017;7(x):xx-xx.

Taro Yamashita, et al: Molecular pathogenesis of hepatocellular carcinoma. Am J Cancer Res 2017;7(x):xx-xx.

Bin Guo, et al: Regulation of histone methylation by cancer chemopreventive agents. Am J Cancer Res 2017;7(x):xx-xx.

Michael Ohh, et al: Molecular pathobiology of von Hippel-Lindau disease. Am J Cancer Res 2017;7(x):xx-xx.

Sean Bong Lee, et al: Wnt Signaling Pathway and Wilms Tumor. Am J Cancer Res 2017;7(x):xx-xx.

R. Daniel Bonfil, et al: Mechanisms of prostate cancer bone metastasis. Am J Cancer Res 2017;7(x):xx-xx.

Fei Chen, et al:  Does apoptosis facilitate carcinogenesis? Am J Cancer Res 2017;7(x):xx-xx.

G. Steven Bova, et al: Why integrated clinical-molecular autopsy studies are critical to future advances in personalized medicine. Am J Cancer Res 2017;7(x):xx-xx.

Tom Luedde, et al: Inflammatory signaling pathways in hepatocarcinogenesis: From Mouse models to new therapeutic strategies? Am J Cancer Res 2017;7(x):xx-xx.

Arnold Chin, et al: Toll-like Receptors in Cancer. Am J Cancer Res 2017;7(x):xx-xx.

Ignacio Perez-Roger, et al: proteasome inhibitors in leukemia. Am J Cancer Res 2017;7(x):xx-xx.

Ceshi Chen, et al: The Hippo tumor suppressor pathway and breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Martin Dutertre, et al: The emerging role of RNA-binding proteins in oncogenesis and stress responses. Am J Cancer Res 2017;7(x):xx-xx.

Kyu-Won Kim, et al: Roles of ARD1 variants in tumor-angiogenesis. Am J Cancer Res 2017;7(x):xx-xx.

Olivier Gires, et al: Cancer stem cell markers and their respective functions. Am J Cancer Res 2017;7(x):xx-xx.

Fahri Saatcioglu, et al: Regulation of apoptosis in prostate cancer cells by androgens (review). Am J Cancer Res 2017;7(x):xx-xx.

Cristiano Ferlini, et al: Cytoskeletal driven mechanisms of drug resistance in solid tumors. Am J Cancer Res 2017;7(x):xx-xx.

Ramana Davuluri, et al: Alternative promoter genes in development and cancer. Am J Cancer Res 2017;7(x):xx-xx.

Yin-Yuan Mo, et al: Role of tumor suppressive microRNAs in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Ajay Goel, et al: Cancer chemoprevention by dietary agents. Am J Cancer Res 2011;1(1):xx-xx. Am J Cancer Res 2017;7(x):xx-xx.

Jean-Ehrland Ricci, et al:  Metabolic control of cell deaths. Am J Cancer Res 2017;7(x):xx-xx.

Kiyoshi Ariizumi, et al:  The role of co-inhibitory receptors in suppression of anti-tumor T cells by melanoma. Am J Cancer Res 2017;7(x):xx-xx.

Jianhua Luo, et al: Integrin and malignancies.  Am J Cancer Res 2017;7(x):xx-xx.

Jörg Wischhusen, et al: Immunological characteristics of cancer stem cells - what do we know? Am J Cancer Res 2017;7(x):xx-xx..

Yoh Takuwa, et al: Role of the lysophospholipid mediator sphingosine-1-phosphate in tumor angiogenesis. Am J Cancer Res 2017;7(x):xx-xx.

Yaacov Ben-David, et al: The role of transcription factor Fli-1 in development and malignant transformation. Am J Cancer Res 2017;7(x):xx-xx.

Rozita Bagheri-Yarmand, et al: The transcription factor ATF4: a novel tumor suppressor gene in breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Yun Wu, et al: Neuroendocrine carcinomas of the breast are resistant to neoadjuvant chemotherapy. Am J Cancer Res 2012;2(x):xx-xx.

Stéphan Vagner, et al: mRNA 3' end heterogeneity in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Jae-Hong Kim, et al: BLT2, a low-affinity receptor for leukotriene B4, is associated with paclitaxel resistance in breast MCF7/ADR cells. Am J Cancer Res 2017;7(x):xx-xx.

Keshav Singh, et al: InterGenomic cross talk and its role in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Gareth Inman, et al: Targeting BMP signaling for cancer therapy. Am J Cancer Res 2017;7(x):xx-xx.

Gareth Inman, et al: Smad activation in Ovarian Cancer. Am J Cancer Res 2017;7(x):xx-xx.

Shazib Pervaiz, et al: Redox regulation of cell fate in cancer cells. Am J Cancer Res 2017;7(x):xx-xx.

Zhihua Liu, et al: S100 protein family and cancer. Am J Cancer Res 2017;7(x):xx-xx.

Hongchuan Jin, et al: Epigenetic silencing of KL in gastric cancer. Am J Cancer Res 2017;7(x):xx-xx.

Eldad Zacksenhaus, et al: Cancer stem cells at single cell resolution. Am J Cancer Res 2017;7(x):xx-xx.

Mathias Chamaillard, et al: Licensing intestinal homeostasis and tumorigenesis by the inflammasome. Am J Cancer Res 2017;7(x):xx-xx.

Federica Cavallo, et al: Oncoantigens for the immunological prevention of cancer. Am J Cancer Res 2017;7(x):xx-xx.

Roberto Chiarle, et al: Anaplastic Lymphoma Kinase and oncogenic signals in tumors. Am J Cancer Res 2017;7(x):xx-xx.

Xin-yuan Guan, et al: Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Am J Cancer Res 2017;7(x):xx-xx.

Mohamed El-Tanani, et al: Genetic regulation of human breast cancer metastasis. Am J Cancer Res 2017;7(x):xx-xx.

Gudrun Koehl, et al: Can mTOR inhibition prevent tumor progression or is it only slowing tumor growth? Am J Cancer Res 2017;7(x):xx-xx.

Torben F. Orntoft, et al: Molecular biomarkers for bladder cancer, the use of combined parameters for disease course prediction. Am J Cancer Res 2017;7(x):xx-xx.

Roberto Diaz, et al: Radiation-Induced Neoantigens: Imaging and Therapeutic Implications. Am J Cancer Res 2017;7(x):xx-xx.

A. Postigo, et al: ZEB proteins as key regulators of cancer stem cells and tumor invasiveness and metastasis. Am J Cancer Res 2017;7(x):xx-xx.

Chenguang Wang, et al: Cyclin D1 regulation of gene transcription. Am J Cancer Res 2017;7(x):xx-xx.

Preet M. Chaudhary, et al: KSHV vFLIP induced genes is primary effusion lymphoma. Am J Cancer Res 2017;7(x):xx-xx.

Jean-Baptiste Vincourt, et al: Consequences of Outside-In Signaling: a matter of ECM integrity. Am J Cancer Res 2017;7(x):xx-xx.

Yong Liao, et al: Oncogenic phophatase Wip1 as a therapeutic target for chemosensitization in human breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Yong Liao, et al: Nuclear reprogramming and oncogenesis. Am J Cancer Res 2017;7(x):xx-xx.

Jean-Baptiste Vincourt, et al: TGF-receptor independent modulation of Smad signaling by procollagen propeptides. Am J Cancer Res 2017;7(x):xx-xx.

Grigory Dianov, et al: Targeting base excision repair for cancer therapy. Am J Cancer Res 2017;7(x):xx-xx.

Lucia Altucci, et al: The Epigenome of cancer: a new era for targets and therapy. Am J Cancer Res 2017;7(x):xx-xx.

Christophe Cazaux, et al: Misregulation of genes involved in DNA repair and DNA damage checkpoint confers a poor prognosis in breast cancer patients. Am J Cancer Res 2017;7(x):xx-xx.

Namhoon Cho, et al: miRNA regulation to affect hormonal refractory prostate cancer. Am J Cancer Res 2017;7(x):xx-xx.

Giovanni Melillo, et al: Targeting the hypoxic tumor microenvironment for cancer therapy. Am J Cancer Res 2017;7(x):xx-xx.

Thomas Reinheckel, et al: Cysteine cathepsins as targets for cancer therapy: lessons from mouse models. Am J Cancer Res 2017;7(x):xx-xx.

Simone Fulda, et al: Targeting apoptosis signaling for cancer therapy. Am J Cancer Res 2017;7(x):xx-xx.

David “Neil” Hayes, et al: The Genomics of Lung Cancer and its role in clinical practice, biomarkers, and model systems. Am J Cancer Res 2017;7(x):xx-xx.

Peter Shaw, et al: Dynamic and interactive properties of ETS  transcription factors linked to tumor development. Am J Cancer Res 2017;7(x):xx-xx.

Habib Boukerche, et al: MDA-9/syntenin, angiogenesis and tumor progression. Am J Cancer Res 2017;7(x):xx-xx.

Shigeomi Shimizu, et al: Molecular mechanisms of alternative autophagy. Am J Cancer Res 2017;7(x):xx-xx.

Thomas Iftner, et al: Physical state and viral load as predictive biomarkers for persistence and progression of high risk HPV-infected cervical lesions: data from a population based prospective cohort follow up of 8656 women for 12 years. Am J Cancer Res 2017;7(x):xx-xx.

Nicholas A Saunders, et al: molecular targeted therapies and traditional chemotherapeutics: what will be best for patients. Am J Cancer Res 2017;7(x):xx-xx.

Stephen T.C. Wong, et al: New systems biology approach for cancer drug repositioning and combination. Am J Cancer Res 2017;7(x):xx-xx.

Ahmed Ashour Ahmed, et al: Aiming at a moving target: targeting mitosis in canccer. Am J Cancer Res 2017;7(x):xx-xx.

Eva M. Harth, et al: Tumor regression of non-small lung cancer with targeted nanosponge delivery system. Am J Cancer Res 2017;7(x):xx-xx.

Sebastien Jauliac, et al: NFAT and cancer: the Ying and the Yang. Am J Cancer Res 2017;7(x):xx-xx.

Jose L. Yelamos, et al: PARP proteins: New players in tumours development. Am J Cancer Res 2017;7(x):xx-xx.

Dosik Min, et al:  Regulation of Phospholipase D expression in Cancer. Am J Cancer Res 2017;7(x):xx-xx.

Aart Jochemsen, et al: The regulation and functions of MDMX. Am J Cancer Res 2017;7(x):xx-xx.

Michael Hsiao, et al: Platform development for high-throughput identifications and validations of novel tumor-associate genes. Am J Cancer Res 2017;7(x):xx-xx.

Albert S Mellick, et al: Small RNAs and bone marrow mediated tumour vascularisation. Am J Cancer Res 2017;7(x):xx-xx.

Albert S Mellick, et al: Endothelial progenitor cells and clinical course and late stage cancer. Am J Cancer Res 2017;7(x):xx-xx.

Gary W. Reuther, et al: Recent advances in JAK2 function in myeloproliferative neoplasms. Am J Cancer Res 2017;7(x):xx-xx.

Pierre Laurent-Puig, et al: EGFR mutated lung cancers a specific disease? Am J Cancer Res 2017;7(x):xx-xx.

Serge Roche, et al: Src family tyrosine kinase signalling in advanced colon carcinoma. Am J Cancer Res 2017;7(x):xx-xx.

Horng-Mo Lee, et al: Nodal is a key molecular switch in regulating aerobic glycolysis in human glioma cells. Am J Cancer Res 2017;7(x):xx-xx.

Nelson Dusetti, et al: TP53INP1 a tumor suppressor gene early disrupted in digestive tract cancerogenesis. Am J Cancer Res 2017;7(x):xx-xx.

David J. MacEwan, et al: MicroRNAs as a new therapeutic target for leukemia. Am J Cancer Res 2017;7(x):xx-xx.

Peter Igaz, et al: Novel aspects of adrenocortical and adrenomedullary tumorigenesis. Am J Cancer Res 2017;7(x):xx-xx.

David Bates, et al: Mechanisms of lymphatic metastasis. Am J Cancer Res 2017;7(x):xx-xx.

Raymond L. Stallings, et al: The role of microRNAs in pediatric cancers. Am J Cancer Res 2017;7(x):xx-xx.

Francoise Redini, et al: How can the micro-environment influence primary bone tumor progression. Am J Cancer Res 2012;2(x):xx-xx.

Andreas G. Bader, et al: Development of microRNA therapeutics. Am J Cancer Res 2017;7(x):xx-xx.

Carlo Gambacorti-Passerini, et al: The development of imatinib for Chronic Myeloid Leukemia. Am J Cancer Res 2017;7(x):xx-xx.

Chang-Deng Hu, et al., ATF2: subcellular localization and oncogenic activity. Am J Cancer Res 2017;7(x):xx-xx.

Fuyu Tamanoi: Mesoporous silica nanoparticles as a delivery system for anticancer drugs and siRNA. Am J Cancer Res 2017;7(x):xx-xx.

Maria Kavallaris, et al: Aurora Kinase Inhibitors in Cancer Therapy. Am J Cancer Res 2017;7(x):xx-xx.

Victoria Cowling, et al: The role of the 7-methylguanosine cap in tumours. Am J Cancer Res 2017;7(x):xx-xx.

Valeria Poli, et al: Stat3 and cancer: dangerous liaisons at multiple levels. Am J Cancer Res 2017;7(x):xx-xx.

Lisa D. Belmont, et al: Pre-clinical models identify predictive biomarkers for the combination of a Bcl-2/Bcl-xL inhibitor and paclitaxel in ovarian cancer. Am J Cancer Res 2017;7(x):xx-xx.

Weinong Han, Mei Ming, and Yu-Ying He: Sensitization of apoptosis of keratinocytes in response to ultraviolet damage. Am J Cancer Res 2017;7(x):xx-xx.

Najmunnisa Nasreen, Nazli Khodayari, Kamal A. Mohammed: Advances in malignant mesothelioma therapy: targeting EphA2 - a novel approach. Am J Cancer Res 2017;7(x):xx-xx.

Ralph Wasch, et al:  Cell cycle regulation in acute leukemia. Am J Cancer Res 2017;7(x):xx-xx.

Alain Piche, et al: Death receptors and ovarian cancer: The TRAILs of resistance. Am J Cancer Res 2017;7(x):xx-xx.

John A. Copland, et al: Novel molecular targets for therapy in renal cell carcinoma.  Am J Cancer Res 2017;7(x):xx-xx.

John A. Copland, et al: Foxo3a as a novel target for therapy.  Am J Cancer Res 2017;7(x):xx-xx.

Nathalie Andrieu-Abadie, et al: Ceramide and Bcl-2 family members in cancer cell signaling. Am J Cancer Res 2017;7(x):xx-xx.

Jeniffer Y. Zhang, et al: Differential roles of JNK or (AP1 proteins) in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Claudio Brancolini, et al: Class IIA HDAC in the control of cell proliferation.  Am J Cancer Res 2017;7(x):xx-xx.

Brigitte N. Gomperts, et al: Stem cells in lung cancer. Am J Cancer Res 2017;7(x):xx-xx.

Kairbaan Hodivala-Dilke: Tumour angiogenesis and new insights. Am J Cancer Res 2017;7(x):xx-xx.

Lesley Stark, et al: Nucleolar translocation of NF-kappaB/RelA in the anti-cancer effects of non-steroidal anti-inflammatory drugs. Am J Cancer Res 2017;7(x):xx-xx.

Annie Huang, et al: Myc - a recurrent problem in medulloblastoma. Am J Cancer Res 2017;7(x):xx-xx.

Irina Nazarenko, et al: A comparative analysis of the binding capacity of tumour-derived exosomes to their target cells: impact of receptor-ligand interactions. Am J Cancer Res 2017;7(x):xx-xx.

Kirsten Ness, et al: Disability and social isolation in adult survivors of childhood brain tumors. Am J Cancer Res 2017;7(x):xx-xx.

Kirsten Ness, et al: Musculoskeletal late effects in childhood cancer survivors. Am J Cancer Res 2017;7(x):xx-xx.

Deng-Shun Wang, et al: DH-PH domain-containing proteins and human cancer.  Am J Cancer Res 2017;7(x):xx-xx.

Farbod Shojaei, et al: identification of biomarkers of resistance to angiogenic inhibitors. Am J Cancer Res 2017;7(x):xx-xx.

Monique A. Spillman, et al: ETV4 is differentially regulated by estrogen in breast cancer cells versus ovarian cancer cells. Am J Cancer Res 2017;7(x):xx-xx.

Vincent Giguère, et al: Estrogen-related receptors in breast cancer: at the crossroad of estrogen and HER-2 signalling. Am J Cancer Res 2017;7(x):xx-xx.

Simon Saule, et al: Akirin2 increased expression correlates with  survival in metastatic uveal melanoma patients. Am J Cancer Res 2017;7(x):xx-xx.

Aleksander S. Popel, et al: Computational models of antiangiogenic therapies in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Zong Sheng Guo, et al: Cancer epigenetics and therapeutic implications. Am J Cancer Res 2017;7(x):xx-xx.

Hongwu Chen, et al: Epigenetic regulator networks in cancer progression. Am J Cancer Res 2017;7(x):xx-xx.

Jaydutt V. Vadgama, et al: Obesity and Breast Cancer. Am J Cancer Res 2017;7(x):xx-xx.

Laura Bracci, et al: Rationale for efficient combination of chemotherapy and immunotherapy against cancer. Am J Cancer Res 2017;7(x):xx-xx.

Jaydutt V.  Vadgama, et al: Role of FOXO1A in Cancer. Am J Cancer Res 2017;7(x):xx-xx.

Wenzheng Zhang, et al: Epigenetics of breast cancer and chronic kidney disease. Am J Cancer Res 2017;7(x):xx-xx.

Pranela Rameshwar, et al: AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells. Am J Cancer Res 2017;7(x):xx-xx.

Ben Wielockx, et al: HIF prolyl hydroxylases and their intriguing role during tumor development. Am J Cancer Res 2017;7(x):xx-xx.

Hiroshi Nakagawa, et al: Hypoxia regulates insulin-like growth factor binding protein 3 in esophageal squamous cell carcinoma. Am J Cancer Res 2017;7(x):xx-xx.

Keiran S. Smalley, et al: Therapeutic targeting of BRAF wild-type melanoma. Am J Cancer Res 2017;7(x):xx-xx.

John Lynch, et al: The role for autophagy in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Am J Cancer Res 2017;7(x):xx-xx.

Joaquín V. Arribas López, et al: Signaling by HER2 fragments. Am J Cancer Res 2017;7(x):xx-xx.

Wei Xu, et al: Recent advance in protein O-glycosylation in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Rajgopal Govindarajan, et al: Pancreatic cancer chemotherapy: progress and future. Am J Cancer Res 2017;7(x):xx-xx.

Hava Gil-Henn, et al: Invadopodia put the foot in the door. Am J Cancer Res 2017;7(x):xx-xx.

Elizabeth Hopper-Borge, et al: Are ABC transporters relevant to breast cancer? Am J Cancer Res 2017;7(x):xx-xx.

Yun Yen, et al: Salivary gland and clinical management. Am J Cancer Res 2017;7(x):xx-xx.

Li Jiao, et al: Dietary intake and tumor microenvironment. Am J Cancer Res 2017;7(x):xx-xx.

Courtney W. Houchen, et al: Comparative evaluation of novel putative stem cell markers and tumor suppressor microRNAs in Barrett’s esophagus. Am J Cancer Res 2017;7(x):xx-xx.

Bernard S. Lopez, et al: DNA double strand break repair in mammalian cells: competition canonical NHEJ versus Alternative NHEJ; consequence on genome stability-instability and on radiation therapy strategies. Am J Cancer Res 2017;7(x):xx-xx.

José Courty, et al: Glycoaminoglycans modulate antitumor activity of peudopeptides that target nucleoproteins. Am J Cancer Res 2017;7(x):xx-xx.

Federica Moschella, et al: Immunomodulatory properties of anticancer drugs for improving  the efficacy of cancer immunotherapy. Am J Cancer Res 2017;7(x):xx-xx.

Rosa Marina Melillo, et al: Cancer-related inflammation in thyroid caner. Am J Cancer Res 2017;7(x):xx-xx.

Vijayalakshmi (Viji) Shridhar, et al: Role of endosulfatases HSulf-1 and -2 in women's cancer. Am J Cancer Res 2017;7(x):xx-xx.

Catherine Muller, et al: Stromal Adipocytes : a new component of the tumour microenvironment. Am J Cancer Res 2017;7(x):xx-xx.

Cai Weibo, et al: 64Cu-Labeled AApeptides: A new class of PET tracers for cancer imaging. Am J Cancer Res 2017;7(x):xx-xx.

Eran Andrechek, et al: Integrative genomics and breast cancer, a review. Am J Cancer Res 2017;7(x):xx-xx.

Dan Mercola, et al: Should we treat the “stroma” of Prostate Cancer? Am J Cancer Res 2017;7(x):xx-xx.

Calvin P.H. Vary, et al: Proteomic analysis of endoglin-deficient TRAMP prostate cancer. Am J Cancer Res 2017;7(x):xx-xx.

Bingbing Dai, et al: Molecular mechanism of MEK inhibitor resistance. Am J Cancer Res 2017;7(x):xx-xx.

Jennifer Isaacs, et al: E-cadherin suppression initiates profound genetic and developmental signaling events in prostate cancer. Am J Cancer Res 2017;7(x):xx-xx.

Leland W. K. Chung, et al: Cell signaling network linking cancer growth and metastasis to the skeleton. Am J Cancer Res 2017;7(x):xx-xx.

Richard Kremer, et al: Parathyroid hormone related protein(PTHrP): biology and targeting strategies. Am J Cancer Res 2012;2(x):xx-xx.

Claudia Lanari, et al: Fibroblast growth factor receptors in breast cancer. A stromal-epithelial connection. Am J Cancer Res 2017;7(x):xx-xx.

Rosana Risques, et al: Senescence-associated markers can distinguish ulcerative colitis patients at risk for cancer progression. Am J Cancer Res 2017;7(x):xx-xx.

Robert W. Sobol, Jr., et al: Expression profile modulation in DNA Polymerase ß null mouse embryonic fibroblasts. Am J Cancer Res 2017;7(x):xx-xx.

Shahriar Koochekpour, et al: Prostate cancer biomarkers. Am J Cancer Res 2017;7(x):xx-xx.

Panagiotis A. Konstantinopoulos, et al: The role of oxidative stress in ovarian cancer pathogenesis. Am J Cancer Res 2012;2(x):xx-xx.

Ahmed A Ahmed, et al: Aiming at a moving target: targeting mitosis in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Steven A Johnsen, et al: Cell cycle-dependent regulation of histone mRNA 3’ end processing. Am J Cancer Res 2017;7(x):xx-xx.

Jianxun Song, et al: Development of tumor antigen-specific T lymphocytes from stem cells. Am J Cancer Res 2017;7(x):xx-xx.

Euan Stronach, et al: The DNA damage response to platinum chemotherapy in ovarian cancer. Am J Cancer Res 2017;7(x):xx-xx.

Shiaw-Yih Lin, et al: Replication stress response defects in breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Hani Gabra, et al: The role of OPCML and the IgLON family in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Henning Willers, et al: Preclinical modeling of personalized radiation oncology: obstacles and opportunities. Am J Cancer Res 2017;7(x):xx-xx.

Massimo Broggini, et al: K-RAS as a determinant of response to chemotherapy. Am J Cancer Res 2017;7(x):xx-xx.

Anja van de Stolpe, et al: The future of cancer pathology diagnostics – with a focus on CTC-based diagnostics. Am J Cancer Res 2017;7(x):xx-xx.

Joao Taborda Barata, et al: Beyond expression: regulation of PTEN tumor suppressor activity by posttranslational mechanisms that do not negatively affect PTEN levels. Am J Cancer Res 2017;7(x):xx-xx.

Lu Q. Le, et al: Neurofibromas: cells of origin and the tumor microenvironment. Am J Cancer Res 2017;7(x):xx-xx.

Wafik S. El-Deiry, et al: Novel assay development for biomarker detection on isolated circulating tumor cells. Am J Cancer Res 2017;7(x):xx-xx.

Chun Li, et al: Targeted delivery of nanoparticles targeted to EphB4 receptors. Am J Cancer Res 2017;7(x):xx-xx.

Chris McCabe, et al: Enhancing the sodium iodide symporter in thyroid cancer. Am J Cancer Res 2017;7(x):xx-xx.

Qianben Wang, et al: Role of pioneer transcription factors in prostate cancer. Am J Cancer Res 2017;7(x):xx-xx.

Vasiliki Bravou, et al: Novel insights in colorectal cancer molecular pathogenesis. Am J Cancer Res 2017;7(x):xx-xx.

Seok-Geun Lee, et al: AEG-1 in tumorigenesis of the central nervous system. Am J Cancer Res 2017;7(x):xx-xx.

Suyun Huang, et al: Role of FoxM1 transcription factor in glioblastoma formation and progression. Am J Cancer Res 2012;2(x):xx-xx.

Silvia Deaglio, et al: The tumor microenvironment in chronic lymphocytic leukemia: clues for identifying novel therapeutic targets. Am J Cancer Res 2017;7(x):xx-xx.

Huafeng Zhang, et al: The role of hypoxia and HIF1 in cancer metastasis. Am J Cancer Res 2017;7(x):xx-xx.

Brandon L Pierce, et al: Unidentified genetic variants influence pancreatic cancer risk:  An analysis of the PanScan genome-wide association study. Am J Cancer Res 2017;7(x):xx-xx.

Tao Zhu, et al: New insight of growth hormone and prolactin in cancer development. Review. Am J Cancer Res 2017;7(x):xx-xx.

Tao Zhu, et al: Gene amplification of growth hormone predict a worse survival outcome in breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Rotem Karni, et al: The role of SR proteins in cancer development and progression. Am J Cancer Res 2017;7(x):xx-xx.

Peng Lee, et al: Androgen receptor and cofactors in prostate cancer. Am J Cancer Res 2017;7(x):xx-xx.

Tokuhiro Chano, et al: RB1CC1 interferes in the crosstalk between autophagy and senescence. Am J Cancer Res 2017;7(x):xx-xx.

Ji-Liang Li, et al: Role of Notch signaling in tumor resistance to anti-cancer therapy. Am J Cancer Res 2017;7(x):xx-xx.

Alberto Izzotti, et al: MicroRNA in lung cancer prevention. Am J Cancer Res 2017;7(x):xx-xx.

Wancai Yang, et al: Molecular mechanisms of dietary factors in colorectal cancer prevention. Am J Cancer Res 2017;7(x):xx-xx.

Frederic Bost, et al: Metformin and Cancer. Am J Cancer Res 2017;7(x):xx-xx.

Santiago  Ramón y Cajal Agüeras, et al: Overcoming cellular stress in malignant cells. The role of peIF4E. Am J Cancer Res 2017;7(x):xx-xx.

Alberto Izzotti, et al:  MicroRNA in lung cancer prevention. Am J Cancer Res 2017;7(x):xx-xx.

Daolin Tang, et al: Role of autophagy in pancreatic cancer. Am J Cancer Res 2017;7(x):xx-xx.

Katherine A Vallis, et al: The development of radioimmunoconjugates directed against intra-nuclear targets. Am J Cancer Res 2017;7(x):xx-xx.

Lucia Languino, et al: Integrin signaling in cancer progression. Am J Cancer Res 2017;7(x):xx-xx.

Tao Ye, et al: Histone deacetylase inhibitor, largazole, inhibits hepatocellular carcinoma growth both in vitro and in mouse model system. Am J Cancer Res 2017;7(x):xx-xx.

Andrei Thomas-Tikhonenko, et al: Smad4 inactivation in colon cancer cooperates with deregulation of the Myc oncoprotein to promote tumor angiogenesis. Am J Cancer Res 2017;7(x):xx-xx.

Xiang-Yang (Shawn) Wang, et al: CD204 represses toll-like receptor agonist elicited antigen-specific antitumor immune response. Am J Cancer Res 2017;7(x):xx-xx.

Masahisa Jinushi, et al: The regulatory mechanisms of cancer stem cell activities by immunological niche.  Am J Cancer Res 2017;7(x):xx-xx.

Jeff Holst, et al: Amino acid transport in cancer. Am J Cancer Res 2017;7(x):xx-xx.

Santosh Kesari, et al: Review of leptomeningeal metastasis in breast cancer. Am J Cancer Res 2017;7(x):xx-xx.

Ivano Bertini, et al: Serum metabolomic can improve the identification of early breast cancer patients at risk of disease recurrence. Am J Cancer Res 2017;7(x):xx-xx.

Tatjana Crnogorac-Jurcevic, et al: S100P in pancreatic cancer- from diagnosis to treatment. Am J Cancer Res 2017;7(x):xx-xx.

Tatjana Crnogorac-Jurcevic, et al: miRNAs- a new tool for early pancreas cancer diagnosis? Am J Cancer Res 2017;7(x):xx-xx.

Chun-Yen Lin, et al: The contributions of tumor in the establishment of tolerogenic tumor microenvironment. Am J Cancer Res 2017;7(x):xx-xx.

Ander Matheu Fernandez, et al: SOX genes in glioblastoma and glioma stem cells. Am J Cancer Res 2017;7(x):xx-xx.

Sylvain Meloche, et al: Mk5 in tumor suppression. Am J Cancer Res 2017;7(x):xx-xx.
American Journal of Cancer Research
ISSN: 2156-6976